Does Virginia Medicaid cover GLP-1s for weight loss?
Does Virginia Medicaid cover GLP-1s for weight loss?
Virginia Medicaid covers GLP-1 receptor agonists for obesity, subject to prior authorization. Coverage for type 2 diabetes, for Wegovy's cardiovascular indication and for Zepbound in moderate to severe sleep apnea is required of every state program regardless. So the practical question at a denial is rarely "does my state cover it" but "which indication am I being prescribed this under". The published threshold is: over 40, or over 37 with dyslipidemia, hypertension or type 2 diabetes. For renewal: 6 more months on 5% weight loss; renewals stop once BMI falls under 25. Those criteria are quoted from Virginia Medicaid Service Authorization — Weight Loss Management, read directly rather than summarized from an aggregator. Where the answer is no, the cheapest verified cash route on this site is $129 a month (compounded, not FDA approved; FDA warning letter). The status above is read from the state's own published document rather than a national summary. Last checked 2026-09-05.
What the prior authorization asks for
- BMI threshold
- over 40, or over 37 with dyslipidemia, hypertension or type 2 diabetes
- Tried first
- A non-GLP-1 weight-loss drug has to have been tried and failed, or all of them be intolerable, before a GLP-1 — and the form defines a failed trial: 3 months without losing 10 lb on the stimulant agents or phentermine/topiramate, 6 months without 10 lb on orlistat, 6 months without a 5% body-weight reduction on a GLP-1. The preferred product on the PDL has to have been tried too. An oral GLP-1 needs a documented contraindication to injection, or trial and failure of two injectable products. Nutritional counseling and a physical activity program are conditions of approval, with height, weight and the weight-loss plan documented within the past 60 days.
- To keep it
- 6 more months on 5% weight loss; renewals stop once BMI falls under 25
- Age
- Wegovy and Saxenda 12+, Zepbound, Wegovy HD and Foundayo 18+
- Approval runs for
- 6 months, then 6-month renewals
The threshold is the strictest of the covering states: a BMI of 37 with no risk factor does not qualify.
Both tools fill from these criteria rather than from a template — a prior authorization for Virginia, or a letter appealing a denial. If the plan is not Medicaid, the 9 insurer and program pages cover a different set of rules.
Whatever Virginia decides about obesity, federal law still makes it cover a GLP-1 prescribed for type 2 diabetes, Wegovy for cardiovascular risk reduction and Zepbound for obstructive sleep apnea — the exclusion is written against the use, not the drug. Which approval a weight-loss exclusion cannot reach, and what each label says.
If you end up paying cash
The cheapest verified GLP-1 routes — what you pay per month once titrated, not an introductory rate:
- Strut Health$129/moverified 2026-09-22compounded, not FDA approvedFDA warning letter
- Noom Med$249/moverified 2026-09-22compounded, not FDA approved
- Found$289/moverified 2026-09-22compounded, not FDA approved
Cheaper still, and a different class: Qsymia (phentermine/topiramate) at $75/mo — about 9.8% mean weight loss in its trial, against roughly 15 to 21% for the GLP-1s above. It is a real option and it is not a substitute.
The manufacturer programs cut the first fills further, and each one's catch is printed with it. Write the appeal first if you were refused — it costs nothing and the criteria above are what it has to answer.
Other states with criteria of their own
Source: Virginia Medicaid Service Authorization — Weight Loss Management , effective 2026-07-01. Read on 2026-09-05. Fee-for-service rules; a managed-care plan in Virginia can publish its own formulary and step edits. This is a record of what the payer publishes, not medical or legal advice.